Insider · CIK 0001347039

Xmark Opportunity Partners, LLC

CIK 0001347039 Name as filed on the most recent filing

Filed as Xmark Opportunity Partners, LLC (81)

189 transaction lines · from 81 filings · filed 2006-04-14 to 2013-02-21 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

183 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2007-10-16 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 12,100, acquired Open Form 4 filing 0001005477-07-005371
2007-10-15 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 8,822, acquired Open Form 4 filing 0001005477-07-005371
2007-10-09 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 1,924, acquired Open Form 4 filing 0001005477-07-005264
2007-10-08 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 4,600, acquired Open Form 4 filing 0001005477-07-005264
2007-10-05 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 10,040, acquired Open Form 4 filing 0001005477-07-005264
2007-10-02 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 11,450, acquired Open Form 4 filing 0001005477-07-005218
2007-09-28 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 2 lines 10,005, acquired Open Form 4 filing 0001005477-07-005143
2007-09-27 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 7,100, acquired Open Form 4 filing 0001005477-07-005143
2007-09-25 P, Open-market purchase Genaera CorpGENR 29,950, acquired Open Form 4 filing 0001005477-07-005106
2007-09-24 P, Open-market purchase Genaera CorpGENR 134,258, acquired Open Form 4 filing 0001005477-07-005106
2007-09-17 P, Open-market purchase Genaera CorpGENR 5,579, acquired Open Form 4 filing 0001005477-07-004983
2007-09-06 P, Open-market purchase Genaera CorpGENR 9,150, acquired Open Form 4 filing 0001005477-07-004850
2007-09-05 P, Open-market purchase Genaera CorpGENR 46,175, acquired Open Form 4 filing 0001005477-07-004850
2007-09-05 P, Open-market purchase Genaera CorpGENR 48,197, acquired Open Form 4 filing 0001005477-07-004799
2007-08-31 P, Open-market purchase Genaera CorpGENR 34,120, acquired Open Form 4 filing 0001005477-07-004799
2007-08-30 P, Open-market purchase Genaera CorpGENR 17,267, acquired Open Form 4 filing 0001188112-07-002676
2007-08-29 P, Open-market purchase Genaera CorpGENR 8,467, acquired Open Form 4 filing 0001188112-07-002676
2007-08-28 P, Open-market purchase Genaera CorpGENR 88,503, acquired Open Form 4 filing 0001188112-07-002676
2007-08-22 P, Open-market purchase Genaera CorpGENR 13,995, acquired Open Form 4 filing 0001188112-07-002625
2007-08-21 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 5,050, acquired Open Form 4 filing 0001005477-07-004588
2007-08-20 P, Open-market purchase Genaera CorpGENR 8,609, acquired Open Form 4 filing 0001005477-07-004586
2007-08-17 P, Open-market purchase Genaera CorpGENR 109,694, acquired Open Form 4 filing 0001005477-07-004586
2007-08-17 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 5,000, acquired Open Form 4 filing 0001005477-07-004588
2007-08-16 P, Open-market purchase Genaera CorpGENR 21,431, acquired Open Form 4 filing 0001005477-07-004507
2007-08-15 P, Open-market purchase Genaera CorpGENR 32,470, acquired Open Form 4 filing 0001005477-07-004507
2007-08-15 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 5,850, acquired Open Form 4 filing 0001005477-07-004588
2007-08-14 P, Open-market purchase Genaera CorpGENR 173,113, acquired Open Form 4 filing 0001005477-07-004470
2007-08-14 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 1,174, acquired Open Form 4 filing 0001005477-07-004588
2007-08-13 P, Open-market purchase Genaera CorpGENR 17,906, acquired Open Form 4 filing 0001005477-07-004470
2007-08-13 P, Open-market purchase Aeolus Pharmaceuticals, Inc.AOLS.OB 2,722, acquired Open Form 4 filing 0001005477-07-004588
2007-08-10 P, Open-market purchase Genaera CorpGENR 40,751, acquired Open Form 4 filing 0001005477-07-004416
2007-08-09 P, Open-market purchase Genaera CorpGENR 29,171, acquired Open Form 4 filing 0001005477-07-004416
2007-08-08 P, Open-market purchase Genaera CorpGENR 148,665, acquired Open Form 4 filing 0001005477-07-004344
2007-08-07 P, Open-market purchase Genaera CorpGENR 174,453, acquired Open Form 4 filing 0001005477-07-004344
2007-08-06 P, Open-market purchase Genaera CorpGENR 13,430, acquired Open Form 4 filing 0001005477-07-004344
2007-08-01 P, Open-market purchase Genaera CorpGENR 3,000, acquired Open Form 4 filing 0001005477-07-004216
2007-07-31 P, Open-market purchase Genaera CorpGENR 2 lines 120,392, acquired Open Form 4 filing 0001005477-07-004216
2007-07-30 P, Open-market purchase Genaera CorpGENR 2 lines 56,205, acquired Open Form 4 filing 0001005477-07-004216
2007-07-27 P, Open-market purchase Genaera CorpGENR 80,103, acquired Open Form 4 filing 0001005477-07-004117
2007-07-25 P, Open-market purchase Genaera CorpGENR 2 lines 66,299, acquired Open Form 4 filing 0001005477-07-004117
2007-07-24 P, Open-market purchase Genaera CorpGENR 32,381, acquired Open Form 4 filing 0001005477-07-004094
2007-07-23 P, Open-market purchase Genaera CorpGENR 27,189, acquired Open Form 4 filing 0001005477-07-004094
2007-07-18 P, Open-market purchase Genaera CorpGENR 32,267, acquired Open Form 4 filing 0001005477-07-004022
2007-07-17 P, Open-market purchase Genaera CorpGENR 86,117, acquired Open Form 4 filing 0001005477-07-004022
2007-07-16 P, Open-market purchase Genaera CorpGENR 33,989, acquired Open Form 4 filing 0001005477-07-005446
2007-07-13 P, Open-market purchase Genaera CorpGENR 35,484, acquired Open Form 4 filing 0001005477-07-005446

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 180
  • Open-market sale 3
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Xmark Opportunity Partners, LLC, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001347039

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.